RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were mostly higher this morning, with the Dow futures gaining around 100 points on Monday.
今天美股盘前，纳斯达克期货上涨，道琼斯期货上涨约100点。
Shares of RXO, Inc.. (NYSE:RXO) shares rose sharply in today's pre-market trading after the company inked a definitive agreement to acquire Coyote Logistics from United Parcel Service, Inc. (NYSE:UPS) for $1.025 billion in cash.
联合包裹公司从RXO公司以10.25亿美元现金收购Coyote 物流公司，目前在纽交所正股盘前交易中，RXO股价大涨。
As per the terms, the transaction disclosed on Sunday will be financed through a combination of equity and debt, including a $300 million equity investment from MFN Partners and a $250 million equity investment from Orbis Investments, both significant shareholders of RXO.
根据协议，本次交易的资金来自股权和债务的组合，包括MFN Partners的3亿美元股权投资和Orbis Investments的2.5亿美元股权投资，两者均为 RXO的重要股东。
RXO shares jumped 13.3% to $22.90 in pre-market trading.
在美股盘前交易中，RXO股票暴涨13.3%，目前股价为22.90美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是在今天美股盘前交易中录得下跌的一些大型股票。
- Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares gained 38.8% to $230.00 in pre-market trading after announcing topline results from its HELIOS-B Phase 3 study of vutrisiran.
- Altimmune, Inc. (NASDAQ:ALT) shares gained 10.9% to $7.10 in pre-market trading after the company announced that it presented data from the 48-week Phase 2 MOMENTUM clinical trial of pemvidutide at the American Diabetes Association's 84th Scientific Sessions.
- Clover Health Investments, Corp. (NASDAQ:CLOV) gained 9.6% to $1.37 in pre-market trading after gaining over 21% on Friday.
- argenx SE (NASDAQ:ARGX) shares gained 9.9% to $433.52 in pre-market trading after the company announced the FDA approval of VYVGART Hytrulo for chronic inflammatory demyelinating polyneuropathy.
- Intellia Therapeutics, Inc. (NASDAQ:NTLA) shares gained 9.5% to $26.51 in pre-market trading.
- Pharming Group N.V. (NASDAQ:PHAR) shares gained 8.1% to $7.86 in pre-market trading after declining 8% on Friday.
- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) shares gained 5.2% to $44.01 in pre-market trading.
- Alnylam Pharmaceuticals在HELIO-B第3期研究中宣布vutrisiran的顶线结果，现在在美股盘前交易中，其股票涨了38.8%，目前股价为230美元。
- Altimmune公司宣布，在美国糖尿病协会84次科学会议上，公布了pemvidutide 48周第2期MOMENTUM临床试验结果。目前该公司股票在美股盘前上涨10.9%，现股价为7.10美元。
- Clover Health Investments在上周五收盘前，股价上涨超过21%，现在在美股盘前交易中，股票价格再次上涨了9.6%，目前股价为1.37美元。
- 在美股盘前交易中，argenx se公司股价上涨9.9%，目前股价为433.52美元，该公司宣布获得FDA批准上市药品VYVGART Hytrulo，用于慢性炎性脱髓鞘性多神经病。
- Intellia Therapeutics公司股票价格在美股盘前上涨9.5%，目前股价为26.51美元。
- Pharming Group公司股票在上周五下跌了8%，现在在美股盘前交易中，股票价格上涨了8.1%，目前股价为7.86美元。
- Ionis Pharmaceuticals股票价格在美股盘前上涨5.2%，目前股价为44.01美元。
Now Read This: Investor Optimism Improves Despite Stocks Ending Mixed On Friday: S&P 500 Closes Lower With Nvidia Dropping Over 3%, Dow Jones Ends Marginally Higher
投资者对未来持乐观态度，尽管周五美股表现不佳，标普500指数收低，Nvidia股价下跌超过3%，道琼斯指数微幅收涨。
Don't forget to check out our premarket coverage here
别忘了查看我们的盘前报道。